Objective To assess the effectiveness of hydroxychloroquine in patients admitted to hospital
with coronavirus disease 2019 (covid-19) pneumonia who require oxygen. Design …

Background Elevated proinflammatory cytokines are associated with greater COVID-19 severity.
We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, …

The current outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
disease 2019 (COVID-19) represents a source of concern for the management of patients with …

Background Treatments are urgently needed to prevent respiratory failure and deaths from
coronavirus disease 2019 (COVID-19). Hydroxychloroquine (HCQ) has received worldwide …

The circulating metabolome provides a snapshot of the physiological state of the organism
responding to pathogenic challenges. Here we report alterations in the plasma metabolome …

Warm autoimmune hemolytic anemia (wAIHA) is a rare autoimmune disease with poorly
known natural history and management remaining mainly empirical. To better describe the …

In the context of COVID-19 pandemic and growing tensions worldwide regarding healthcare
facilities, there is an urgent need for effective treatments likely to reduce the crunch of ICU …

Background Safety of HPV vaccines is still in question due to reports of autoimmune diseases
(ADs) following HPV immunization. Objectives To assess the risk of ADs associated with …

Background High levels of serum interleukin-6 (IL-6) correlate with disease severity in COVID-19.
We hypothesized that tocilizumab (a recombinant humanized anti-IL-6 receptor) could …

FIP1L1‐PDGFRA‐positive myeloid neoplasm with eosinophilia (F/P+ MN‐eo) is a rare disease:
robust epidemiological data are lacking and reported issues are scarce, of low sample‐…